Regardless of the mechanism, the finding that urate-associated genetic variants at SLC2A9 could affect serum urate levels via epigenetic mechanisms may be of potential clinical relevance, as each SD higher DNA methylation at CpGs at SLC2A9 conferred up to 57% lower odds of gout, the most common form of inflammatory arthritis in adults. Here, SLC2A9 is linked to gout.